等离子增强微阵列免疫分析用于心力衰竭生物标志物高灵敏监测
Plasmonically Enhanced Microarray Immunoassay for High‐Sensitivity Monitoring of Heart Failure
一种集成nanopatch天线的等离子增强荧光微阵列免疫分析结合自制智能手机检测器,实现NT-proBNP、NGAL和galectin-3的定量多重检测,荧光增强最高达485倍,检测限分别为0.055、3.932和0.864 ng/mL。NT-proBNP阳性人体样本分析显示与临床验证方法强相关。
- 背景
- 即时检测需要兼顾分析灵敏度与小型低成本读取硬件,而荧光免疫分析在探测器成本与检测性能之间难以两全。等离激元纳米腔(如金属—介质—金属纳米贴片天线)能显著增强荧光团发光,有望用廉价光学实现灵敏荧光检测。
- 做法
- 研究将纳米贴片天线整合进荧光微阵列免疫分析,针对心衰标志物 NT‑proBNP、NGAL 和 galectin‑3 进行定量检测,读取端采用自制的智能手机探测器。
- 结论
- 纳米贴片天线带来最高 485 倍荧光增强,三种标志物的检测限分别为 0.055、3.932 和 0.864 ng/mL,可实现定量与多重检测。NT‑proBNP 阳性人样本的分析结果与临床验证方法显示强相关性。
- 意义
- 该平台在低成本条件下完成心衰标志物的高灵敏监测,指向资源有限与即时检测场景。文中仅报告了 NT‑proBNP 阳性样本与临床方法的相关性,其余标志物的临床样本验证情况未在摘要中说明。
原文摘要
出版方登记 · CrossrefPoint‑of‑care testing (POCT) demands diagnostic platforms that pair high analytical sensitivity with compact, low‑cost readout hardware, yet fluorescence‑based immunoassays face a fundamental tradeoff between detector cost and detection performance. Plasmonic nanocavities—such as metal–dielectric–metal nanopatch antennas—offer a powerful signal‑amplification strategy by dramatically enhancing fluorophore emission, enabling sensitive fluorescence detection with inexpensive optics. Here, we introduce a plasmonically enhanced fluorescence microarray immunoassay that integrates nanopatch antennas for high‑sensitivity, low‑cost quantification of key heart‑failure biomarkers, NT‑proBNP, NGAL, and galectin‑3, using a custom smartphone‑based detector. The nanopatch antennas yield up to 485‑fold fluorescence enhancement enabling quantitative and multiplexed detection with limits of detection of 0.055, 3.932, and 0.864 ng/mL, respectively. Analysis of NT‑proBNP–positive human samples shows strong correlation with clinically validated assays, demonstrating the potential of this plasmonically enhanced platform to deliver high‑performance heart‑failure biomarker monitoring at low cost in resource‑limited and point‑of‑care settings.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
本页是 AI 精读,不转载论文原文;完整论文(含方法、图表与参考文献)见原文
来源:Advanced Materials · doi.org